Literature DB >> 8385563

Upper gastrointestinal manifestations in families with hereditary flat adenoma syndrome.

H T Lynch1, T C Smyrk, S J Lanspa, J X Jenkins, P M Lynch, J Cavalieri, J F Lynch.   

Abstract

BACKGROUND: The hereditary flat adenoma syndrome (HFAS) is characterized by an autosomal dominantly inherited predisposition to multiple colonic adenomas (usually less than 100) with proximal predominance and flat as opposed to polypoid growth. Patients with the syndrome experience colorectal cancers in excess, and the lesions are distributed randomly in the colon. The polyps occur at a later age (median, 55 years) compared with age at onset of polyps in patients with familial adenomatous polyposis (FAP) and patients with the Lynch syndromes. FAP and HFAS are linked to the same locus on chromosome 5q21-q22.
METHODS: Upper endoscopic examination was performed on 22 relatives from four families with HFAS.
RESULTS: Fifteen patients from three of these families had multiple fundic gland polyps; four had duodenal or gastric adenomas. Periampullary carcinoma was present in two members from separate families.
CONCLUSIONS: The authors conclude that the upper gastrointestinal tract pathologic characteristics of HFAS are similar to those described in FAP. Thus, those at risk for HFAS require upper endoscopic screening in addition to meticulous attention to the colon.

Entities:  

Mesh:

Year:  1993        PMID: 8385563     DOI: 10.1002/1097-0142(19930501)71:9<2709::aid-cncr2820710904>3.0.co;2-t

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  12 in total

1.  FAP, gastric cancer, and genetic counseling featuring children and young adults: a family study and review.

Authors:  Henry T Lynch; Carrie Snyder; Janine M Davies; Stephen Lanspa; Jane Lynch; Zoran Gatalica; Victoria Graeve; Jason Foster
Journal:  Fam Cancer       Date:  2010-12       Impact factor: 2.375

2.  Familial adenomatous polyposis: more evidence for disease diversity and genetic heterogeneity.

Authors:  R J Scott; C Meldrum; R Crooks; A D Spigelman; J Kirk; K Tucker; D Koorey
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

3.  Fundic gland polyps.

Authors:  P Declich; C Galli; G Isimbaldi; M Sironi
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

Review 4.  Helicobacter pylori eradication to prevent gastric cancer: underlying molecular and cellular mechanisms.

Authors:  Shingo Tsuji; Masahiko Tsujii; Hiroaki Murata; Tsutomu Nishida; Masato Komori; Masakazu Yasumaru; Shuji Ishii; Yoshiaki Sasayama; Sunao Kawano; Norio Hayashi
Journal:  World J Gastroenterol       Date:  2006-03-21       Impact factor: 5.742

5.  Extracolonic manifestations of hereditary colorectal cancer syndromes.

Authors:  Daniel A Anaya; George J Chang; Miguel A Rodriguez-Bigas
Journal:  Clin Colon Rectal Surg       Date:  2008-11

6.  Phenotypic differences in familial adenomatous polyposis based on APC gene mutation status.

Authors:  K Heinimann; B Müllhaupt; W Weber; M Attenhofer; R J Scott; M Fried; S Martinoli; H Müller; Z Dobbie
Journal:  Gut       Date:  1998-11       Impact factor: 23.059

Review 7.  [Hereditary colorectal cancer].

Authors:  G Möslein
Journal:  Chirurg       Date:  2008-11       Impact factor: 0.955

Review 8.  Preventive surgery for colon cancer in familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer syndrome.

Authors:  Gabriela Möslein; Steffen Pistorius; Hans-Detlev Saeger; Hans K Schackert
Journal:  Langenbecks Arch Surg       Date:  2003-03-27       Impact factor: 3.445

9.  Synchronous primary carcinomas of the ampulla of Vater and ascending colon in a patient with multiple flat adenomas.

Authors:  Marko Doko; Mario Zovak; Elizabet Glavan; Mario Kopljar; Davor Tomas
Journal:  Int J Gastrointest Cancer       Date:  2003

10.  Correlation between the development of extracolonic manifestations in FAP patients and mutations beyond codon 1403 in the APC gene.

Authors:  Z Dobbie; M Spycher; J L Mary; M Häner; I Guldenschuh; R Hürliman; R Amman; J Roth; H Müller; R J Scott
Journal:  J Med Genet       Date:  1996-04       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.